Avisa Financial Statements From 2010 to 2025
Avisa Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avisa Diagnostics' valuation are provided below:Avisa Diagnostics does not presently have any fundamental signals for analysis.
This module can also supplement various Avisa Diagnostics Technical models . Check out the analysis of Avisa Diagnostics Correlation against competitors.
Check Avisa Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avisa Diagnostics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Avisa financial statements analysis is a perfect complement when working with Avisa Diagnostics Valuation or Volatility modules.
Avisa |
Avisa Diagnostics Company Current Valuation Analysis
Avisa Diagnostics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avisa Diagnostics Current Valuation | 9.09 M |
Most of Avisa Diagnostics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avisa Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avisa Diagnostics has a Current Valuation of 9.09 M. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Avisa Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avisa Diagnostics's current stock value. Our valuation model uses many indicators to compare Avisa Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avisa Diagnostics competition to find correlations between indicators driving Avisa Diagnostics's intrinsic value. More Info.Avisa Diagnostics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avisa Diagnostics' earnings, one of the primary drivers of an investment's value.About Avisa Diagnostics Financial Statements
Avisa Diagnostics stakeholders use historical fundamental indicators, such as Avisa Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Avisa Diagnostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avisa Diagnostics' assets and liabilities are reflected in the revenues and expenses on Avisa Diagnostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avisa Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Avisa Pink Sheet
Avisa Diagnostics financial ratios help investors to determine whether Avisa Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avisa with respect to the benefits of owning Avisa Diagnostics security.